Insight
CFPB Order Makes it Clear: Nonbanks Should Prepare for CFPB Supervision
by John Coleman, Amanda Lawrence and Jeffrey Naimon
8 minute read | March.01.2024

by John Coleman, Amanda Lawrence and Jeffrey Naimon
8 minute read | March.01.2024
by Patricia L. Eichar, Devin Brennan, Jenna Magan and Stephen Spitz
10 minute read | February.29.2024
by Jeremiah Buckley and Caroline Stapleton
February.28.2024
25 minute read | February.26.2024
Women's & Reproductive Health
by Paul F. Rugani
5 minute read | February.26.2024
by Jeremiah Buckley and Sherry-Maria Safchuk
February.21.2024
by Jeremiah Buckley and Caroline Stapleton
February.14.2024
by Jeremiah Buckley and Sasha Leonhardt
February.07.2024
by Jeremiah Buckley and Sasha Leonhardt
January.31.2024
by Stephen Thau, Albert Vanderlaan and George Pothoulakis
6 minute read | January.30.2024
Reverse mergers have helped biotech companies access public markets, but recent SEC positions are threatening that path to going public.
by Adam Smith, Evan Stergoulis, Karthik Kumar, Minako Wakabayashi, Paul Zarnowiecki, Dr. Werner Brickwedde and Geoffroy Berthon
1 minute read | January.29.2024
by Jeremiah Buckley and Sherry-Maria Safchuk
January.24.2024